Tag: watchman

Boston Scientific Corporation WATCHMAN FLX Device
March 15, 2023/Electrophysiology

Watchman FLX at 1 Year: Real-World Performance Consistent With Trial Results

Large SURPASS registry study confirms high seal rates, acceptable safety

December 8, 2022/Geriatrics

Left Atrial Appendage Closure Is Safe to Consider Even in the Very Elderly

Large database analysis finds no rise in in-hospital mortality relative to younger patients

The Featured Image for the post
March 16, 2022/Electrophysiology

SURPASS Study Confirms Real-World Safety and Efficacy of Watchman FLX Through 45 Days

Interim report from large registry analysis compares favorably with pivotal trial

21-HVI-2489560-Watchman 1000+_650x450
November 9, 2021/Electrophysiology

Insights From 1,000+ Left Atrial Appendage Closure Procedures With Watchman

Even very high-risk patients benefit, and implantation can safely be combined with ablation or TAVR


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy


Launching an LAAO Program: How Cleveland Clinic Assisted an Affiliated Institution

A Missouri center turns lessons from a site visit into program success

February 6, 2019/Advancing Patient Care

Left Atrial Appendage Closure Device Found Safe and Effective for AF Despite Prior ICH

Study supports new stroke prevention option for high-risk group

May 11, 2018/Research

Watchman in the Real World: Reports on Use in High-Risk Patients and Overall Safety

Recaps of three studies from Cleveland Clinic’s experience to date

October 29, 2015/Neurosciences

Options Expanding for Patients Who Require Anticoagulation

New medications, occlusive device now available

BackPage 1 of 1Next